Advertisement NovaRay names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NovaRay names new CFO

NovaRay Medical, a developer of digital cardiac X-ray imaging technology and the ScanCath cardiac catheterization system, has appointed Will Frederick as its new CFO. He will be reporting to Jack Price, president and CEO.

Mr Frederick brings to NovaRay 20 years of financial leadership in strategic planning, financial reporting, mergers, acquisitions and international finance. Prior to joining NovaRay, Mr Frederick was senior vice president and CFO at Pharsight, a provider of software, strategic consulting and regulatory services for optimizing clinical drug development.

Before Pharsight, Mr Frederick was the CFO of Versata, a provider of business rules management software and services for developing data-intensive applications.

Mr Price said: “Will brings a well rounded skill set and a proven ability to develop successful financial strategies for a wide range of companies with growth opportunities similar to NovaRay. We believe Will’s expertise will add depth to our organization and we look forward to his many contributions.”